(Q45275583)

English

Early haemodynamic benefit of sildenafil in patients with coexisting chronic thromboembolic pulmonary hypertension and left ventricular dysfunction

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 December 2017

Early haemodynamic benefit of sildenafil in patients with coexisting chronic thromboembolic pulmonary hypertension and left ventricular dysfunction (English)

1 reference

Europe PubMed Central

11 December 2017

Chronic Thromboembolic Pulmonary Hypertension

0 references

1 reference

based on heuristic

inferred from title

thromboembolism

1 reference

based on heuristic

inferred from title

ventricular dysfunction

1 reference

based on heuristic

inferred from title

author name string

Abhijat Sheth

1

1 reference

Europe PubMed Central

11 December 2017

John E S Park

2

1 reference

Europe PubMed Central

11 December 2017

Yee Ean Ong

3

1 reference

Europe PubMed Central

11 December 2017

Timothy B Ho

4

1 reference

Europe PubMed Central

11 December 2017

Brendan P Madden

5

1 reference

Europe PubMed Central

11 December 2017

publication date

18 January 2005

1 reference

Europe PubMed Central

11 December 2017

Vascular Pharmacology

1 reference

Europe PubMed Central

11 December 2017

42

1 reference

Europe PubMed Central

11 December 2017

2

1 reference

Europe PubMed Central

11 December 2017

41-45

1 reference

Europe PubMed Central

11 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.11.005

7 January 2021

Effect of PDE5 inhibition on coronary hemodynamics in pacing-induced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.11.005

7 January 2021

Chronic thromboembolic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.11.005

7 January 2021

Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.11.005

7 January 2021

Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.11.005

7 January 2021

Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.11.005

7 January 2021

Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.11.005

7 January 2021

Prognostic factors in medically treated patients with chronic pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.11.005

7 January 2021

Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.11.005

7 January 2021

Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.11.005

7 January 2021

Identifiers

10.1016/J.VPH.2004.11.005

1 reference

Europe PubMed Central

11 December 2017

1 reference

Europe PubMed Central

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45275583&oldid=2072308598"